breast implant-associated anaplastic large-cell lymphoma

August 1, 2019

Allergan Issues Worldwide Recall of Some Breast Implant Products Due to Lymphoma Risk

News

Allergan has issued a worldwide recall of its BIOCELL textured breast implant products, due to the potential risk of breast implant-associated anaplastic large cell lymphoma (BIA-ALCL). The recall — for Allergan’s proprietary ... Read more

March 28, 2018

FDA Examines Anaplastic Large-cell Lymphoma Link to Breast Implants

News

The number of reported cases of breast-implant-associated anaplastic large-cell lymphoma (BIA-ALCL) has risen, according to the U.S. Food and Drug Administration (FDA). The increase in known cases may be due ... Read more

January 10, 2018January 10, 2018

Breast Implants Associated with Small Increased Risk of Anaplastic Large-cell Lymphoma

News

A study found that one in 6,920 women with breast implants will develop anaplastic large-cell lymphoma (ALCL) in the breast before they reach the age of 75. Even though the ... Read more

December 4, 2015December 4, 2015

Breast Implant-linked Lymphomas Best Treated by Surgical Removal, Study Finds

News

According to the results of an international study led by researchers at The University of Texas MD Anderson Cancer Center, the optimal treatment for most women with breast implant-associated anaplastic large-cell lymphoma (BI-ALCL) ... Read more